GlassScriptPhysician profile
Sanjeev Michael Osuri
NPI 1619193547
$747.05
in general payments reported to CMS, 2019-2025
15 companies · $179 in 2025
The $179 reported for 2025 was more than what 78% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $75.18 · 2021: $13.39 · 2022: $64.60 · 2023: $183 · 2024: $44.24 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $249.32 | 2019-2025 | Bridion |
| Medtronic, INC. | $136.77 | 2023-2025 | Micra, Aurora Ev-Icd Mri Surescan, Pulseselect |
| Janssen Pharmaceuticals, INC | $51.37 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.25 | 2023-2025 | |
| Endo USA, INC. | $36.80 | 2024-2025 | Aveed, Xiaflex |
| Endo Pharmaceuticals INC. | $33.92 | 2021-2023 | Aveed, Edex, Xiaflex |
| Biosense Webster, INC. | $31.24 | 2022 | |
| Heron Therapeutics, INC. | $26.30 | 2023 | Zynrelef |
| Eagle Pharmaceuticals, INC. | $22.59 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $22.28 | 2025 | Exparel |
| Mallinckrodt Hospital Products INC. | $21.55 | 2020 | |
| Antares Pharma, INC. | $19.51 | 2023 | Xyosted, Tlando, Nocdurna |
| Mallinckrodt Enterprises LLC | $17.96 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.83 | 2023 | Givlaari |
| Stryker Corporation | $15.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeev Osuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.